Kaa. Fox et al., Inter-regional differences and outcome in unstable angina - Analysis of the International ESSENCE trial, EUR HEART J, 21(17), 2000, pp. 1433-1439
Aims Worldwide there is a large Variation in outcome (death, myocardial inf
arction and recurrent myocardial infarction) in patients with unstable angi
na or non-Q wave myocardial infarction. These variations may be explained b
y differences in characteristics of the presenting patients. Here we descri
be differences in patient presentation, treatment protocols and outcome and
we investigate their relationship using data from the ESSENCE (Efficacy an
d Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) trial. M
ethods A total of 2981 patients from six countries which enrolled more than
100 patients were included in the present analysis: United States, Canada,
Argentina, France, the Netherlands and United Kingdom. Logistic regression
analysis was performed to determine the effect of baseline characteristics
on regional outcome.
Results At day 30, the lowest triple end-point rate, irrespective of study
drug treatment, was noted in the Netherlands (18.9%) and the highest in Arg
entina (30.5%). A model including the variables age greater than or equal t
o 65 years, prior angina, diabetes, prior aspirin use? ECG changes at basel
ine and diagnosis of non-Q wave myocardial infarction and dummy variables f
or Argentina and France resulted in concordance of about 60%.
Conclusions Inter-regional differences in outcome in unstable angina and no
n-Q wave myocardial infarction patients can reasonably well be explained by
differences in patient characteristics. However, other so far unidentified
variables present in Argentina and France also contributed to differences
in outcome and their effect warrants further investigation. (C) 2000 The Eu
ropean Society of Cardiology.